Evercore ISI analyst Umer Raffat ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA Hot Comments Momentum Movers Trader Talk

MacroGenics (MGNX) PT Raised to $40 at SunTrust Robinson HumphreyFebruary 6, 2019 1:30 PM Macrogenics (MGNX) Adds to Gains, Up 140%February 6, 2019 9:06 AM Macrogenics (MGNX) Climbs 100% After Reporting Positive Results from Pivotal Phase 3 SOPHIA Study of MargetuximabFebruary 6, 2019 7:55 AM Macrogenics (MGNX) Reports Positive Results from Pivotal Phase 3 SOPHIA Study of MargetuximabFebruary 6, 2019 6:00 AM MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of MargetuximabFebruary 6, 2019 6:00 AM